CORPORATE PRESENTATION
We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.
Quarterly Results
Press Releases
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host a webcast to review data from the successful TETON-2 pivotal study...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Martine Rothblatt, Ph.D., Chairperson and Chief...
Results of the successful phase 3 TETON-2 study of inhaled treprostinil in idiopathic pulmonary fibrosis will be presented in an oral presentationSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS...
Positive results were observed across all subgroupsStudy meets several key secondary endpoints with statistical significanceSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics...
29 Aug 2025
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and...
01 Aug 2025
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
Repurchase reflects the strength of United Therapeutics’ balance sheet and confidence in its near-term prospectsSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation...
Events and presentations
28 Sep 2025
Phase 3 TETON-2 Results Conference Call
12:30 PM ET
23 Sep 2025
Bernstein 2nd Annual Healthcare Forum
01:10 PM ET
08 Sep 2025
Morgan Stanley 23rd Annual Global Healthcare Conference
03:20 PM ET
30 Jul 2025
United Therapeutics Second Quarter 2025 Financial Results
09:00 AM ET
30 Apr 2025
United Therapeutics First Quarter 2025 Financial Results
09:00 AM ET
11 Mar 2025
Leerink Partners Global Healthcare Conference
10:00 AM ET